Patient Tolerability Study of GSK163090
NCT00559299
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Depressive Disorder, Major
Major Depressive Disorder (MDD)
Interventions
DRUG:
GSK163090
Sponsor
GlaxoSmithKline